CURASEN THERAPEUTICS, INC.

Profile

Company Names

CURASEN THERAPEUTICS, INC.

Addresses

733 INDUSTRIAL ROAD, SAN CARLOS, CA 94070

930 BRITTAN RD., STE. 306, SAN CARLOS, CA 94070

2655 CAMPUS DRIVE, SUITE 110, SAN MATEO, CA 94403

Phone Numbers

650-475-2842
(650) 475-2842
(650) 475-2841

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$68,635,010.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-08-26 
$5,785,019.00 
$45,690,305.00 
$39,905,286.00 
Equity 
3
2022-11-01 
$17,599,997.00 
$20,814,709.00 
$3,214,712.00 
Equity 
2
2021-10-21 
$18,000,000.00 
$18,000,000.00 
$0.00 
Equity 
1
2018-09-18 
$27,249,994.00 
$54,499,989.00 
$27,249,995.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICK 
 
ENRIGHT 
DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  CARDIODX INC   |  LONGITUDE VENTURE PARTNERS II, L.P.   |  INFACARE PHARMACEUTICAL CORP   |  ESPERION THERAPEUTICS, INC.   |  ALLERGEN RESEARCH CORP   |  SUTROVAX, INC.   |  ORBUS THERAPEUTICS, INC.   |  LONGITUDE VENTURE PARTNERS III, L.P.   |  ROCK STARR LLC   |  ROCKPOINT LLC   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  STICHTING ADMINISTRATIEKANTOOR SYNCREON   |  VERA THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.   |  LONGITUDE VENTURE PARTNERS V, L.P.   |  LONGITUDE PRIME FUND II, L.P.   |  BIOAGE LABS, INC.   |  VERADERMICS, INC   |  LONGITUDE 103.8 EAST, L.P.   |  INFINANT HEALTH, INC.
ANTHONY 
P 
FORD 
DIRECTOR, EXECUTIVE OFFICER
CURASEN THERAPEUTICS, INC.
ANTHONY 
P. 
FORD 
EXECUTIVE OFFICER, DIRECTOR
CURASEN THERAPEUTICS, INC.
KATHLEEN 
SEREDA 
GLAUB 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  CURASEN THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC
RON 
 
HUNT 
DIRECTOR
SPINE WAVE, INC   |  KALIDEX PHARMACEUTICALS, INC.   |  ILLUMINOSS MEDICAL INC   |  RELYPSA INC   |  NEW LEAF GROWTH FUND I, L.P.   |  NEURONETICS, INC.   |  HARPOON THERAPEUTICS, INC.   |  QLARIS BIO, INC.   |  RALLYBIO HOLDINGS, LLC   |  CURASEN THERAPEUTICS, INC.
BENJAMIN 
 
POTTER 
EXECUTIVE OFFICER
CURASEN THERAPEUTICS, INC.
LIAM 
 
RATCLIFFE 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  NEURONETICS, INC.   |  UNUM THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEW LEAF GROWTH FUND I, L.P.   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  ARVINAS, INC.   |  ELIEM THERAPEUTICS, INC.   |  HALDA THERAPEUTICS, LLC
HENRY 
 
SKINNER 
DIRECTOR
AVILA THERAPEUTICS INC   |  THESAN PHARMACEUTICALS, INC.   |  AEGLEA BIOTHERAPEUTICS HOLDINGS, LLC   |  GALERA THERAPEUTICS, INC.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  PROTEOSTASIS THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  CAVION, INC.   |  NEUROVIA, INC.   |  GENOMEDX INC.   |  CURASEN THERAPEUTICS, INC.   |  DECIPHER BIOSCIENCES, INC.
SIMON 
 
TATE 
DIRECTOR
ELIEM THERAPEUTICS, INC.   |  BIOINTERVENE, INC.   |  CURASEN THERAPEUTICS, INC.
SIMON 
 
TATE, PH.D. 
DIRECTOR
CURASEN THERAPEUTICS, INC.
LORETTA 
 
TSE, PH.D. 
DIRECTOR
CURASEN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-09-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-26 
2023-10-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-01 
2022-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-01 
2021-11-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-21 
2019-01-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#